Shana J Sturla Selected Research

illudin S

1/2013	Quantification of acylfulvene- and illudin S-DNA adducts in cells with variable bioactivation capacities.
11/2011	Chemical and enzymatic reductive activation of acylfulvene to isomeric cytotoxic reactive intermediates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shana J Sturla Research Topics

Disease

25	Neoplasms (Cancer) 02/2024 - 08/2006
8	Carcinogenesis 01/2021 - 02/2003
5	Colonic Neoplasms (Colon Cancer) 01/2016 - 01/2013
3	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2019
3	Hypoxia (Hypoxemia) 01/2018 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2023 - 05/2011
1	Alzheimer Disease (Alzheimer's Disease) 01/2024
1	Inflammation (Inflammations) 01/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 10/2021
1	Fatty Liver 05/2020
1	Genomic Instability 10/2018
1	Iron Deficiencies 05/2017
1	Leukemia 12/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2013
1	Liver Neoplasms (Liver Cancer) 11/2012
1	Drug-Related Side Effects and Adverse Reactions 10/2007

Drug/Important Bio-Agent (IBA)

12	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2006
11	DNA AdductsIBA 01/2020 - 02/2003
3	Antineoplastic Agents (Antineoplastics)IBA 02/2024 - 01/2011
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 05/2006
3	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 01/2015
3	ProdrugsIBA 01/2017 - 12/2015
2	NucleotidesIBA 03/2023 - 10/2018
2	MutagensIBA 01/2023 - 01/2016
2	Temozolomide (Temodar)FDA LinkGeneric 10/2021 - 01/2019
2	A-Form DNA (A-DNA)IBA 10/2021 - 10/2018
2	3-hydroxycholest-7-ene-14-carbaldehydeIBA 01/2021 - 03/2014
2	CarcinogensIBA 01/2019 - 01/2017
2	PR-104AIBA 01/2018 - 01/2016
2	Aldo-Keto ReductasesIBA 01/2017 - 03/2014
2	Alkylating AgentsIBA 01/2016 - 11/2013
2	EnzymesIBA 01/2016 - 01/2015
2	sulforaphaneIBA 01/2016 - 03/2014
2	illudin SIBA 01/2013 - 11/2011
1	Janus Kinase InhibitorsIBA 01/2024
1	tofacitinibIBA 01/2024
1	Janus KinasesIBA 01/2024
1	baricitinibIBA 01/2024
1	Benzo(a)pyreneIBA 01/2023
1	PolyphenolsIBA 01/2023
1	norharmanIBA 01/2023
1	Methylnitronitrosoguanidine (MNNG)IBA 01/2023
1	LipidsIBA 01/2023
1	HydrogelsIBA 01/2023
1	Cytostatic AgentsIBA 10/2021
1	Nitroso CompoundsIBA 01/2021
1	AzaserineIBA 01/2021
1	DeoxyguanosineIBA 01/2021
1	enilconazole (imazalil)IBA 05/2020
1	thiaclopridIBA 05/2020
1	clothianidinIBA 05/2020
1	AminesIBA 01/2019
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2018
1	IronIBA 05/2017
1	Phosphates (Orthophosphate)IBA 05/2017
1	ferric phosphateIBA 05/2017
1	OligonucleotidesIBA 01/2017
1	benzocycloheptapyridineIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	NitrogenIBA 01/2017
1	Oxygen (Dioxygen)IBA 01/2017
1	PlatinumIBA 01/2017
1	Acrolein (Aqualin)IBA 01/2017
1	quinolineIBA 01/2017
1	Bile Acids and Salts (Bile Acids)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2016
1	Mechlorethamine (Nitrogen Mustard)FDA Link 12/2015
1	Sodium SeleniteIBA 01/2015
1	SeleniumIBA 03/2014
1	7-hydroxystaurosporine (UCN 01)IBA 11/2013
1	acylfulveneIBA 11/2013
1	FructoseIBA 07/2013
1	1,2-dithiol-3-thioneIBA 11/2012
1	CurcuminIBA 11/2012
1	ResveratrolIBA 11/2012
1	SesquiterpenesIBA 11/2011
1	5-Methylcytosine (5 Methylcytosine)IBA 05/2011
1	Inositol PhosphatesIBA 03/2008
1	ChlorophenolsIBA 06/2007
1	quinone (benzoquinone)IBA 06/2007
1	nitrosobenzylmethylamineIBA 08/2006
1	O2- (4- (3- pyridyl)- 4- oxobut- 1- yl)thymidineIBA 05/2006

Therapy/Procedure

6	Therapeutics 10/2021 - 03/2008
3	Drug Therapy (Chemotherapy) 10/2021 - 01/2011
1	Aftercare (After-Treatment) 03/2014